Identification of Mutations Conferring Tryptanthrin Resistance to <i>Mycobacterium smegmatis</i>

Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>, is a global burden, responsible for over 1 million deaths annually. The emergence and spread of drug-resistant <i>M. tuberculosis</i> strains (MDR-, XDR- and TDR-TB) is the main challenge in global TB-control, re...

Full description

Saved in:
Bibliographic Details
Main Authors: Svetlana G. Frolova (Author), Ksenia M. Klimina (Author), Ravinder Kumar (Author), Aleksey A. Vatlin (Author), Deepak B. Salunke (Author), Pravin Kendrekar (Author), Valery N. Danilenko (Author), Dmitry A. Maslov (Author)
Format: Book
Published: MDPI AG, 2020-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_eba55414ef7d4fe08d6edc68f9a37f3e
042 |a dc 
100 1 0 |a Svetlana G. Frolova  |e author 
700 1 0 |a Ksenia M. Klimina  |e author 
700 1 0 |a Ravinder Kumar  |e author 
700 1 0 |a Aleksey A. Vatlin  |e author 
700 1 0 |a Deepak B. Salunke  |e author 
700 1 0 |a Pravin Kendrekar  |e author 
700 1 0 |a Valery N. Danilenko  |e author 
700 1 0 |a Dmitry A. Maslov  |e author 
245 0 0 |a Identification of Mutations Conferring Tryptanthrin Resistance to <i>Mycobacterium smegmatis</i> 
260 |b MDPI AG,   |c 2020-12-01T00:00:00Z. 
500 |a 10.3390/antibiotics10010006 
500 |a 2079-6382 
520 |a Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>, is a global burden, responsible for over 1 million deaths annually. The emergence and spread of drug-resistant <i>M. tuberculosis</i> strains (MDR-, XDR- and TDR-TB) is the main challenge in global TB-control, requiring the development of novel drugs acting on new biotargets, thus able to overcome the drug-resistance. Tryptanthrin is a natural alkaloid, with great therapeutic potential due to its simple way of synthesis and wide spectrum of biological activities including high bactericidal activity on both drug-susceptible and MDR <i>M. tuberculosis</i> strains. InhA was suggested as the target of tryptanthrins by in silico modeling, making it a promising alternative to isoniazid, able to overcome drug resistance provided by <i>katG</i> mutations. However, neither the mechanism of action of tryptanthrin nor the mechanism of resistance to tryptanthrins was ever confirmed in vitro. We show that the MmpS5-MmpL5 efflux system is able to provide resistance to tryptanthrins using an in-house test-system. Comparative genomic analysis of spontaneous tryptanthrin-resistant <i>M. smegmatis</i> mutants showed that mutations in <i>MSMEG_1963</i> (EmbR transcriptional regulator) lead to a high-level resistance, while those in <i>MSMEG_5597</i> (TetR transcriptional regulator) to a low-level one. Mutations in an MFS transporter gene (<i>MSMEG_4427</i>) were also observed, which might be involved in providing a basal level of tryptanthrins-resistance. 
546 |a EN 
690 |a tuberculosis 
690 |a mycobacterium smegmatis 
690 |a tryptanthrin 
690 |a drug resistance 
690 |a efflux 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 10, Iss 1, p 6 (2020) 
787 0 |n https://www.mdpi.com/2079-6382/10/1/6 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/eba55414ef7d4fe08d6edc68f9a37f3e  |z Connect to this object online.